Index Every US public charity, on the record

Andy Derr Foundation for Kidney Cancer Research

Fogelsville, Pennsylvania
EIN 81-1302321Grantmaking public charityLatest return year ending December 2025Its profile as a public charity

Applications

Applications

Schedule I of Form 990 lists the grants made, not how to apply, so this return does not say whether Andy Derr Foundation for Kidney Cancer Research accepts applications.

From its returns

What it gave

Andy Derr Foundation for Kidney Cancer Research paid $75,000 in grants in the year ending December 2025.

Grants paid
$75,000
Year ending December 2025
Grants listed
2
To organizations, on that return
Typical grant
$37,500
Half fall between $31,250 and $43,750
Year endingGrants paidGrants listed
December 2025$75,0002
December 2024$55,1762

From Schedule I of its Form 990 returns for the years ending December 2024 to December 2025.

Focus and places

What it funds, and where

From the 4 grants listed on its returns for the years ending December 2024 to December 2025. A grant counts toward a focus only when it is linked to the charity that received it: 0 of 4 are.

Focus, by share of linked grant dollars

None of its grants could be linked to a charity with certainty, so no focus is shown.

Where it gave, by number of grants

  • Pennsylvania4

From Schedule I of its Form 990 returns for the years ending December 2024 to December 2025.

Grants

Recent grants to organizations

The largest grants on its latest returns, as filed. A name links to the charity’s profile when the match is certain.

RecipientYear endingAmountPurpose
LEHIGH VALLEY HEALTH NETWORKAllentown, PennsylvaniaDecember 2025$50,000FUNDING WAS PROVIDED TO THE LEHIGH VALLEY HEALTH NETWORK FOR A NUMBER OF ITS CANCER INSTITUTE'S 2025 AND 2026 INITIATIVES.
ST LUKES HOSPITALBethlehem, PennsylvaniaDecember 2025$25,000FUNDING TO ST LUKE'S UNIVERSITY HEALTH NETWORK WAS FOR THE SECOND YEAR OF THE TWO-YEAR IMMUNE GENE MUTATION RESEARCH PROJECT THAT EXPLORES HOW GENETIC MUTATIONS, SUCH AS BETA-2 MICROGLOBULIN (B2M), AFFECT PATIENT RESPONSE TO IMMUNOTHERAPY IN KIDNEY CANCER. IN ADDITION, THE FUNDS SPONSORED SLUHN'S CONFERENCE ATTENDANCE FOR RESEARCHERS.
LEHIGH VALLEY HEALTH NETWORKAllentown, PennsylvaniaDecember 2024$30,176FUNDING WAS PROVIDED TO THE LEHIGH VALLEY HEALTH NETWORK FOR A NUMBER OF ITS CANCER INSTITUTE'S 2024 AND 2025 INITIATIVES.
ST LUKES HOSPITALBethlehem, PennsylvaniaDecember 2024$25,000FUNDING TO ST LUKE'S UNIVERSITY HEALTH NETWORK WAS FOR A TWO-YEAR IMMUNE GENE MUTATION RESEARCH PROJECT THAT EXPLORES HOW GENETIC MUTATIONS, SUCH AS BETA-2 MICROGLOBULIN (B2M), AFFECT PATIENT RESPONSE TO IMMUNOTHERAPY IN KIDNEY CANCER. OUR SUPPORT NOT ONLY DRIVES CUTTING-EDGE RESEARCH AND DATA ANALYSIS BUT ALSO DEVELOPS FUTURE ONCOLOGY LEADERS THROUGH MENTORSHIP, CONFERENCE PARTICIPATION, AND PUBLICATION OPPORTUNITIES.

Showing 4 of the 4 grants listed on its returns for the years ending December 2024 to December 2025. From Schedule I of its Form 990 returns for the years ending December 2024 to December 2025.